An Assessment of HIV Drug Resistance among Seroconversions in Users of Pre-Exposure Prophylaxis in Kenya
To assess the frequency of HIV-1 drug resistance mutations among PrEP clients who test HIV positive after initiating any PrEP products. Further, the study will explore the relationship between HIV drug resistance and PrEP adherence in individuals who seroconvert on PrEP. Hence, the drug resistance data obtained in the study will inform the national PrEP program and provide guidance to ensure long-term effectiveness of both PrEP and ART in the population. Funded by USAID.
Countries
Active Dates
01/01/2022 to 12/31/2026
Faculty Involved
Health Topics